FDA QSR to QMSR Transition Training – Online

Star icon
Date: Dec 14, 2026
By Sivan Luder
Registration
  • Location: Online
  • Duration: 1 Day
  • Starts at: 09:30
  • Language: Hebrew

QMSR Transition Training: Adapting to the New FDA Regulation

The FDA’s new Quality Management System Regulation (QMSR) has officially replaced 21 CFR Part 820 and incorporates ISO 13485:2016 by reference.

This focused online training provides a clear and practical understanding of the QMSR framework, including its structure, regulatory intent and inspection implications.

The course explains how QMSR affects design controls, supplier management, risk-based processes and quality documentation while clarifying the connection between ISO 13485 clauses and FDA-specific expectations.

The session is intended for organizations preparing for the transition and teams that require structured training and documented competency for audit purposes.

 

Course Details

Date: 14.12.2026
Hours: 09:30–13:00
Format: Online

 

What You Will Learn

  • Understand the regulatory implications of the QMSR final rule
  • Conduct a structured gap assessment between legacy QSR practices and QMSR requirements
  • Identify required updates to SOPs, forms and quality documentation
  • Strengthen risk-based integration across the QMS
  • Prepare for FDA inspections under the QMSR framework
  • Demonstrate formal training and competency during audits

 

Who Should Attend?

Professionals working in the medical device industry, including:

  • Quality and Regulatory
  • R&D and Engineering
  • Manufacturing
  • Clinical teams

 

Prerequisites

  • No prior knowledge is required. However, familiarity with ISO 13485 and ISO 14971 is a significant advantage, as it will deepen participants’ understanding and improve their engagement with the training content.
  • Participants who are unfamiliar with these standards may complete supplementary learning after the course to strengthen their knowledge and gain the full benefit of the QMSR transition training.

 

Sivan Luder

Dr. Sivan Luder is a Regulatory, Clinical, and Quality Expert with a PhD in Molecular Biology and over 10 years of experience across various industries, with a strong focus on the medical device sector. Possesses a deep scientific background and extensive experience in leading the development and implementation of medical devices from concept to commercialization, […]
Read More ›